The development of ARDS is a predictor of high mortality in COVID-19 patients. But clinicians do not currently have a reliable method to predict which patients will develop ARDS. A group of UAB ...

New study in The American Journal of Pathology suggests potential avenues of research to develop new therapies to improve survival and prevent chronic lung disease in COVID-19 and non--COVID-19 acute ...

Point-of-care testing identifies ARDS inflammatory subphenotypes in real time, offering insights into patient prognosis and mortality risks.

Recognition of ventilator-induced lung injury led to the development of the baby lung concept by Luciano Gattinoni1 and to ...

In experiments with ARDS model mice, researchers from Japan found that basophils, a type of white blood cells, release interleukin-4, a signaling molecule that suppresses inflammatory neutrophils ...

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...

Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...

Infant respiratory distress syndrome (RDS), sometimes referred to as neonatal RDS, is most common in babies born prematurely. When babies are born prematurely, their lungs may not be fully developed, ...